Fortress Biotech Inc
FBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$160.67M
Close$
$-2.26
174.5% downside
Current Fair Value
174.5% downsideOvervalued by 174.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $160.67 Million |
|---|---|
| Enterprise Value | $-36,123,255.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.07 |
| Beta | 1.21 |
| Outstanding Shares | 31,540,595 |
Return
| Return on Equity | 74.61% |
|---|---|
| Return on Assets | 33.91% |
| Return on Invested Capital | -11.34% |
Valuation & Multiples
| P/E Ratio | 0.79 |
|---|---|
| PEG | -0.07 |
| Price to Sales | 1.52 |
| Price to Book Ratio | 0.51 |
| Enterprise Value to Revenue | -0.55 |
| Enterprise Value to EBIT | 1.26 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | -1.63 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$16.03 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$18.30 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 29.9508▲ 2041.08% |
|---|---|
| Total Calls | 12,200▼ 77.28% |
| Total Puts | 365,400▼ 28.67% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 19.16%▼ 2.04% |
|---|---|
| Total Invested | $14.92M▼ 29.54% |
| Investors Holding | 560% |
ESG Score
No data
About Fortress Biotech Inc
111 employees
CEO: Lindsay Rosenwald